highly significantP < 0.0005
The highly significant difference ( P < 0.0005) between uptakes in HER2-positive and HER2-negative xenografts at 2 h postinjection confirmed the in vivo targeting specificity.
The highly significant difference ( P < 0.0005) between uptakes in HER2-positive and HER2-negative xenografts at 2 h postinjection confirmed the in vivo targeting specificity.